David Raymond Amos @DavidRayAmos
Replying to @DavidRayAmos @alllibertynews and 49 others
"Content disabled"
Oh My My Methinks Bayer Corp won't appreciate this revelation N'esy Pas?https://davidraymondamos3.blogspot.com/2020/03/new-guidelines-advise-against-taking.html
https://www.cbc.ca/news/health/aspirin-heart-disease-guidelines-1.5506867
New guidelines advise against taking Aspirin to prevent heart disease, first stroke
ASA still 'strongly recommended' for those with stroke, heart disease history
The Canadian Press · Posted: Mar 23, 2020 1:38 PM ET
New guidelines from the Heart and Stroke Foundation say a daily dose of Aspirin should no longer be taken as a preventative measure, though it's still recommended for people with a history of heart disease. (Patrick Sison/Associated Press)
A new guideline
from Heart and Stroke Foundation says a daily dose of Aspirin could do
more harm than good for those at low risk of stroke or heart disease.
The recommendations published Monday in the Canadian Medical Association Journal say acetylsalicylic acid (ASA) should not be taken as a preventive measure for those who do not have a history of stroke, heart or vascular disease.
That's a major shift from the decades-old practice calling for a daily, low dose of ASA, which in addition to Aspirin is also known by the brand names Entrophen and Novasen.
The
Heart and Stroke writing group, chaired by McGill University
neurologist Dr. Theodore Wein, developed the guideline after strong new
research linked daily ASA doses to serious side effects such as internal
bleeding.
Wein says the new recommendations only apply to those who have not had a stroke, heart condition or peripheral artery disease.
He says it is still "strongly recommended" that anyone with a history of stroke, or heart or vascular disease continue to take low-dose, daily ASA to prevent another event, if their doctor has prescribed the treatment.
CBC's Journalistic Standards and PracticesThe recommendations published Monday in the Canadian Medical Association Journal say acetylsalicylic acid (ASA) should not be taken as a preventive measure for those who do not have a history of stroke, heart or vascular disease.
That's a major shift from the decades-old practice calling for a daily, low dose of ASA, which in addition to Aspirin is also known by the brand names Entrophen and Novasen.
Wein says the new recommendations only apply to those who have not had a stroke, heart condition or peripheral artery disease.
He says it is still "strongly recommended" that anyone with a history of stroke, or heart or vascular disease continue to take low-dose, daily ASA to prevent another event, if their doctor has prescribed the treatment.
65 Comments
Scott Bullerwell
WHAT? There is actually 'other' news besides Covid-19. The CBC is kidding, right?
David Amos
Reply to @Scott
Bullerwell: Nope They ain't joking A thread just went "Poof" for no
reason whatsoever other than malicious political reasons
Micheal McLoughlin
For those who might be wondering why Aspirin is capitalised, it's because it's a brand name for ASA sold by the Bayer (read "buyer") corporation of Germany -- except in the United States, which confiscated all of Bayer's assets during World War I; including Bayer Aspirin.. So, in the USA, all brands of ASA are sold as (lower case) "aspirin" because it's not a brand name in that country. If you say 'ASA' in the USA, most people won't know what you're talking about.
Last time I checked (it's been a while), the Bayer brand of aspirin sold in the USA was owned by the Sterling Drug Company.
David Amos
Reply to @Micheal McLoughlin: Methinks its interesting that you can say Bayer and I can't N'esy Pas?
David Amos
Reply to @Micheal McLoughlin: Methinks folks may enjoy checking out page 26 of a certain document Anyone can Google the following N'esy Pas?
CROSS BORDER Scribd
Sally Casswell
Big pharma had absolutely NO research to support their original claim and has never done any. As well there's NO research that shows an aspirin ever saved anyone's life who suffered a heart attack. Without question one of the most dangerous scams BIG pharma's engaged in as it gave false hope. This immoral campaign gives every reason to literally never trust this pharmaceutical business and I seriously doubt any other is more honest as they all put products on the market without a spec of research to support their claims.
Micheal McLoughlin
Reply to @Sally
Casswell: Your perception of this story is off the mark, along with your
perception of the problem. 1) People who have a history of heart
disease are still recommended to take low dose ASA on a daily basis,
because the natural blood-thinning properties of ASA override other
concerns, 2) The blood-thining properties of ASA have alwasy been
perfectly well-known, and that is why taking it can indeed be helpful if
you have trouble with your circulatory system that can affect your
heart, lungs and brain, 3) The negtive side effects of ASA have also
been well-known for decades, the worst of them being life-threatening
allergy to ASA.
THe article addresses the problem of bleeding that can be caused by ASA, combined with the delay in clotting - because of ASA's blood-thinning properties. The internal bleeding mostly occurs in the stomach - which is why it is so important to drink a full glass of water or milk when you take ASA; but if you take low dose ASA on a daily basis when you have no reason to use a blood thinner, you will have ASA running through your veins and arteries 24/7, and that can have a corrosive effect.
As to "Big Pharma," all they did in most countries was promote pre-existing knowledge of the blood-thinning properties of ASA. If they were able to get away with saying more than that, blame the pertinent government for insufficient regulation of advertising - and advocate for that government to strengthen the rules on what product manufacturers can and cannot say. Complaining about the product manufacturer and/or marketer might *feel* good but *does* no good. All marketers of all products will make any claim they can to make a sale - so the onus is on the buyer and the government to take steps to ensure truth in advertising.
THe article addresses the problem of bleeding that can be caused by ASA, combined with the delay in clotting - because of ASA's blood-thinning properties. The internal bleeding mostly occurs in the stomach - which is why it is so important to drink a full glass of water or milk when you take ASA; but if you take low dose ASA on a daily basis when you have no reason to use a blood thinner, you will have ASA running through your veins and arteries 24/7, and that can have a corrosive effect.
As to "Big Pharma," all they did in most countries was promote pre-existing knowledge of the blood-thinning properties of ASA. If they were able to get away with saying more than that, blame the pertinent government for insufficient regulation of advertising - and advocate for that government to strengthen the rules on what product manufacturers can and cannot say. Complaining about the product manufacturer and/or marketer might *feel* good but *does* no good. All marketers of all products will make any claim they can to make a sale - so the onus is on the buyer and the government to take steps to ensure truth in advertising.
David Amos
Content disabled
Reply to @Micheal McLoughlin: Methinks you may enjoy checking out page 26 of this document N'esy Pas? https://www.scribd.com/doc/265620671/Cross-Border-Txt
David Amos
Content disabled
Oh My My Methinks Bayer Corp won't appreciate this revelation N'esy Pas?
Steve Haywood
Content disabled Before I could read it
Reply to @David Amos
Michael Harris
David Amos
Content disabled
Reply to @Steve Haywood: You must be a liberal or even worst, an NDP'er.....
Fritz Mahngoy
Content disabled
Reply to @David Amos: did you mean n'est ce pas?
David Amos
Content disabled
Reply to @Michael Harris: Methinks you should Google me before you embarrass yourself further N'esy Pas?David Amos
Content disabled
Reply to @Fritz Mahngoy: Nope
No comments:
Post a Comment